Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Opthea ( (AU:OPT) ) has provided an announcement.
Opthea Limited has released its Corporate Governance Statement for the financial year ending June 30, 2025. The statement, approved by the board and current as of September 15, 2025, outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for maintaining transparency and accountability, impacting Opthea’s operations and positioning within the industry by ensuring compliance with regulatory standards.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited operates in the biotechnology industry, focusing on developing and commercializing therapies for eye diseases, particularly those related to retinal conditions.
YTD Price Performance: -25.93%
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
See more insights into OPT stock on TipRanks’ Stock Analysis page.